Panitumumab
Vectibix (panitumumab) is a prescription monoclonal antibody made by Amgen that targets epidermal growth factor receptors to help treat certain cancers, like metastatic colorectal cancer. It's given as an intravenous infusion. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Vectibix (panitumumab) is a prescription monoclonal antibody made by Amgen that targets epidermal growth factor receptors to help treat certain cancers, like metastatic colorectal cancer. It's given as an intravenous infusion. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Panitumumab",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Panitumumab — ANDA 125147 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147"
}
]
|
| identifier | ANDA125147 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"fda",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Panitumumab |
